WEISBLUM ERIC (CHIEF EXECUTIVE OFFICER) purchased 2.7% of their position (4.51K shares) of SILO PHARMA, INC. on the open market
Open‑market purchase worth $8.7K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 4/1/2024ACC: 0001213900-24-028973
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Apr 2020
+4.51K
Net shares
Net buyer
$8.7K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
4.51K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.41K
Price / share
$1.94
Trade value
$6.61K
% of position
2.0%
3/28/2024
169.92K→173.33K
Common Stock
Direct
Shares
+1.10K
Price / share
$1.91
Trade value
$2.10K
% of position
0.6%
4/1/2024
173.33K→174.43K
Total
Net shares
+4.51K
Net value
$8.71K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/28/2024 | P · Purchase | +3.41K | $1.94 | $6.61K | 2.0% | 169.92K | 173.33K |
| Common Stock Direct | 4/1/2024 | P · Purchase | +1.10K | $1.91 | $2.10K | 0.6% | 173.33K | 174.43K |
| Total | +4.51K | $8.71K | ||||||
Derivative Transactions0
No derivative transactions reported